Bolt Biotherapeutics names Sheila Gujrathi chief strategy officer
BOLT•Bolt Biotherapeutics appointed Sheila Gujrathi chief strategy officer and a board member in connection with its October 23, 2026, acquisition of Prana Therapies.
1. Leadership appointment
Bolt Biotherapeutics appointed Sheila Gujrathi chief strategy officer and a board member in connection with its acquisition of Prana Therapies on October 23, 2026. Gujrathi co-founded Prana and was its chief executive officer.
